Back to Search Start Over

Priming the Abscopal Effect Using Multifunctional Smart Radiotherapy Biomaterials Loaded with Immunoadjuvants

Authors :
Michele Moreau
Sayeda Yasmin-Karim
Sijumon Kunjachan
Neeharika Sinha
Felix Gremse
Rajiv Kumar
Kwok Fan Chow
Wilfred Ngwa
Source :
Frontiers in Oncology, Frontiers in Oncology, Vol 8 (2018), Frontiers in oncology 8, 56 (2018). doi:10.3389/fonc.2018.00056
Publication Year :
2018
Publisher :
Frontiers Media SA, 2018.

Abstract

In this study, we investigate the use of multifunctional smart radiotherapy biomaterials (SRBs) loaded with immunoadjuvants for boosting the abscopal effect of local radiotherapy (RT). SRBs were designed similar to currently used inert radiotherapy biomaterials, incorporating a biodegradable polymer with reservoir for loading payloads of the immunoadjuvant anti-CD40 monoclonal antibody. Lung (LLC1) tumors were generated both on the right and left flank of each mouse, with the left tumor representing metastasis. The mice were randomized and divided into 8 cohorts with 4 cohorts receiving image-guided radiotherapy (IGRT) at 5 Gy and another similar 4 cohorts at 0 Gy. IGRT and Computed Tomography (CT) imaging were performed using a small animal radiation research platform (SARRP). Tumor volume measurements for both flank tumors and animal survival was assessed over 25 weeks. Tumor volume measurements showed significantly enhanced inhibition in growth for the right flank tumors of mice in the cohort treated with SRBs loaded with CD40 mAbs and IGRT. Results also suggest that the use of polymeric SRBs with CD40 mAbs without RT could generate an immune response, consistent with previous studies showing such response when using anti-CD40. Overall, 60% of mice treated with SRBs showed complete tumor regression during the observation period, compared to 10% for cohorts administered with anti-CD40 mAbs but no SRB. Complete tumor regression was not observed in any other cohorts. The findings justify more studies varying RT doses and quantifying the immune-cell populations involved when using SRBs. Such SRBs could be developed to replace currently used radiotherapy biomaterials, allowing not only for geometric accuracy during RT but also for extending RT to the treatment of metastatic lesions.

Details

ISSN :
2234943X
Volume :
8
Database :
OpenAIRE
Journal :
Frontiers in Oncology
Accession number :
edsair.doi.dedup.....14bd0aa67c8a3cdb3448b7882d49bb01
Full Text :
https://doi.org/10.3389/fonc.2018.00056